Compare COKE & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COKE | RVTY |
|---|---|---|
| Founded | 1902 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 11.6B |
| IPO Year | 1994 | 1994 |
| Metric | COKE | RVTY |
|---|---|---|
| Price | $181.36 | $110.84 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $109.67 |
| AVG Volume (30 Days) | 551.0K | ★ 1.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.50% | 0.34% |
| EPS Growth | ★ 156.81 | N/A |
| EPS | ★ 1.21 | 0.36 |
| Revenue | ★ $7,228,055,000.00 | $3,311,822,000.00 |
| Revenue This Year | N/A | $6.37 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ $147.64 | $309.11 |
| Revenue Growth | ★ 4.76 | N/A |
| 52 Week Low | $110.55 | $81.22 |
| 52 Week High | $218.73 | $118.30 |
| Indicator | COKE | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 58.56 |
| Support Level | $175.11 | $108.02 |
| Resistance Level | $182.49 | $117.23 |
| Average True Range (ATR) | 7.83 | 3.10 |
| MACD | -0.77 | -0.40 |
| Stochastic Oscillator | 46.43 | 38.51 |
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.